TY  - GEN
AU  - Huang,R Stephanie
AU  - Johnatty,Sharon E
AU  - Gamazon,Eric R
AU  - Im,Hae Kyung
AU  - Ziliak,Dana
AU  - Duan,Shiwei
AU  - Zhang,Wei
AU  - Kistner,Emily O
AU  - Chen,Peixian
AU  - Beesley,Jonathan
AU  - Mi,Shuangli
AU  - O'Donnell,Peter H
AU  - Fraiman,Yarden S
AU  - Das,Soma
AU  - Cox,Nancy J
AU  - Lu,Yi
AU  - Macgregor,Stuart
AU  - Goode,Ellen L
AU  - Vierkant,Robert A
AU  - Fridley,Brooke L
AU  - Hogdall,Estrid
AU  - Kjaer,Susanne K
AU  - Jensen,Allan
AU  - Moysich,Kirsten B
AU  - Grasela,Matthew
AU  - Odunsi,Kunle
AU  - Brown,Robert
AU  - Paul,Jim
AU  - Lambrechts,Diether
AU  - Despierre,Evelyn
AU  - Vergote,Ignace
AU  - Gross,Jenny
AU  - Karlan,Beth Y
AU  - Defazio,Anna
AU  - Chenevix-Trench,Georgia
AU  - Dolan,M Eileen
TI  - Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients
SN  - 1557-3265
PY  - 2012///0203
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Cell Line
KW  - Cell Line, Tumor
KW  - Female
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - Genome, Human
KW  - genetics
KW  - Genome-Wide Association Study
KW  - methods
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Polymorphism, Single Nucleotide
KW  - Prognosis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1158/1078-0432.CCR-11-0724
ER  -